Capital increase in Deva Holding has been approved by the Capital Market Board
(Thomson Reuters ONE) - Capital increase in Deva Holding has been approved by the Capital Market BoardEASTPHARMA LTD.London, 16 February 2010 - EastPharma (EAST LI), a company active inmanufacturing and marketing of branded generic and in-licensed pharmaceuticalproducts in Turkey and other regional markets, informs that the capital increasein Deva Holding A.S. has been approved by the Capital Market Board of Turkey andsubsequently Deva Holding A.S.'s stock split has been realized as of 11.02.2010on the Istanbul Stock Exchange.Within the registered capital ceiling amounting to 500,000,000 Turkish Liras ofDeva Holding A.S., one of the subsidiaries of EastPharma, the applicationregarding the increase of the issued capital through rights issues from144,000,000 Turkish Liras to 180,000,000 Turkish Liras was approved by theCapital Market Board on 01.02.2010. The rights to purchase shares through rightsissues shall be traded in the Rights Market between 11.02.2010-25.02.2010. Theshare prices shall be made available for 1 Kurus for each share having a nominalvalue of 1 Kurus. Deva minority shareholders can participate to the capitalincrease between the dates 11.02.2010-25.02.2010 for a period of fifteen days.The base prices of the stocks that is traded 'Newly' as of 11.02.2010 as thereferences are stated herein below:The base price of the 'Old' stocks: 3.62 Turkish LirasThe base price of the 'New' stocks: 3.10 Turkish LirasEastPharma S.a.r.l. made the payment of 29,608,075.34 Turkish Liras to DevaHolding regarding the capital increase of Deva Holding, so that the shares heldby EastPharma S.a.r.l totalling to 82.24% in Deva Holding does not change.For further information, please contact:EastPharma Ltd.Idil Bora - Investor RelationsTel: + 90 (212) 6929326[HUG#1384825]
Datum: 16.02.2010 - 09:35 Uhr
Sprache: Deutsch
News-ID 12548
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 157 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Capital increase in Deva Holding has been approved by the Capital Market Board"
steht unter der journalistisch-redaktionellen Verantwortung von
EastPharma Ltd (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
